The Impact of Posttransplant Lymphoproliferative Disease in High-risk Kidney Transplant Recipients: Benefits of Prevention
Background. Posttransplant lymphoproliferative disease (PTLD) is increased in kidney transplant recipients who are Epstein-Barr virus (EBV) nonimmune (R–), particularly if the donor has prior EBV immunity (D+). PTLD is associated with very high mortality. The purpose of this study was to quantify th...
Saved in:
| Main Authors: | Bryce A. Kiberd, MD, Christopher J.A. Daley, BscPharm, ACPR, PharmD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-05-01
|
| Series: | Transplantation Direct |
| Online Access: | http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001792 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Masked Arginine Vasopressin Deficiency in a Kidney Transplant Recipient With Posttransplant Lymphoproliferative Disorder
by: Annie Liu, et al.
Published: (2024-09-01) -
Posttransplant Lymphoproliferative Disease after Lung Transplantation
by: Isabel P. Neuringer
Published: (2013-01-01) -
Posttransplant Lymphoproliferative Disorders
by: Hazem A. H. Ibrahim, et al.
Published: (2012-01-01) -
Posttransplant Lymphoproliferative Disorder Presenting as Testicular Lymphoma in a Kidney Transplant Recipient: A Case Report and Review of the Literature
by: Steve Omoruyi Obanor, et al.
Published: (2018-01-01) -
Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation
by: Martin Mynarek, et al.
Published: (2013-01-01)